|
1
|
Shiba E, Matsuyama A, Shibuya R, Yabuki K,
Harada H, Nakamoto M, Kasai T and Hisaoka M: Immunohistochemical
and molecular detection of the expression of FGF23 in phosphaturic
mesenchymal tumors including the non-phosphaturic variant. Diagn
Pathol. 11:262016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nakamura K, Ohishi M, Matsunobu T,
Nakashima Y, Sakamoto A, Maekawa A, Oda Y and Iwamoto Y:
Tumor-induced osteomalacia caused by a massive phosphaturic
mesenchymal tumor of the acetabulum: A case report. Mod Rheumatol.
4:1–5. 2016.(Epub ahead of print). View Article : Google Scholar
|
|
3
|
Hautmann AH, Schroeder J, Wild P, Hautmann
MG, Huber E, Hoffstetter P, Fleck M and Girlich C: Tumor-induced
osteomalacia: Increased level of FGF-23 in a patient with a
phosphaturic mesenchymal tumor at the tibia expressing periostin.
Case Rep Endocrino. 2014:7293872014.
|
|
4
|
Norden AG, Laing RJ, Rowe P, Unwin RJ,
Wrong O and Crisp AJ: Oncogenic osteomalacia, raised FGF-23 and
renal Fanconi syndrome. QJM. 107:139–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Larsson T, Zahradnik R, Lavigne J,
Ljunggren O, Jüppner H and Jonsson KB: Immunohistochemical
detection of FGF-23 protein in tumors that cause oncogenic
osteomalacia. Eur J Endocrinol. 148:269–276. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dupond JL, Magy N, Mahammedi M, Prie D,
Gil H, Meaux-Ruault N and Kantelip B: Oncogenic osteomalacia: The
role of the phosphatonins. Diagnostic usefulness of the Fibroblast
growth factor 23 measurement in one patient. Rev Med Interne.
26:238–241. 2005.(In French).
|
|
7
|
Nelson AE, Bligh RC, Mirams M, Gill A, Au
A, Clarkson A, Jüppner H, Ruff S, Stalley P, Scolyer RA, et al:
Clinical case seminar: Fibroblast growth factor 23: A new clinical
marker for oncogenic osteomalacia. J Clin Endocrinol Metab.
88:4088–4094. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qari H, Hamao-Sakamoto A, Fuselier C,
Cheng YS, Kessler H and Wright J: Phosphaturic mesenchymal tumor: 2
New oral cases and review of 53 cases in the head and neck. Head
Neck Pathol. 10:192–200. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Okamiya T, Takahashi K, Kamada H, Hirato
J, Motoi T, Fukumoto S and Chikamatsu K: Oncogenic osteomalacia
caused by an occult paranasal sinus tumor. Auris Nasus Larynx.
42:167–169. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ledford CK, Zelenski NA, Cardona DM,
Brigman BE and Eward WC: The phosphaturic mesenchymal tumor: Why is
definitive diagnosis and curative surgery often delayed? Clin
Orthop Relat Res. 471:3618–3625. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chiam P, Tan HC, Bee YM and Chandran M:
Oncogenic osteomalacia-hypophosphataemic spectrum from ‘benignancy’
to ‘malignancy’. Bone. 53:182–187. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Morimoto T, Takenaka S, Hashimoto N, Araki
N, Myoui A and Yoshikawa H: Malignant phosphaturic mesenchymal
tumor of the pelvis: A report of two cases. Oncol Lett. 8:67–71.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
William J, Laskin W, Nayar R and De Frias
D: Diagnosis of phosphaturic mesenchymal tumor (mixed connective
tissue type) by cytopathology. Diagn Cytopathol. 40 Suppl
2:E109–E113. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guglielmi G, Bisceglia M, Scillitani A and
Folpe AL: Oncogenic osteomalacia due to phosphaturic mesenchymal
tumor of the craniofacial sinuses. Clin Cases Miner Bone Metab.
8:45–49. 2011.PubMed/NCBI
|
|
15
|
Chong WH, Molinolo AA, Chen CC and Collins
MT: Tumor-induced osteomalacia. Endocr Relat Cancer. 18:R53–R77.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kaul M, Silverberg M, Dicarlo EF,
Schneider R, Bass AR and Erkan D: Tumor-induced osteomalacia. Clin
Rheumatol. 26:1575–1579. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weidner N and Santa Cruz D: Phosphaturic
mesenchymal tumors. A polymorphous group causing osteomalacia or
rickets. Cancer. 59:1442–1454. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gatti AP, Tonello L, Neto JA, Teixeira UF,
Goldoni MB, Fontes PR, Sampaio JA, Lima LM and Waechter FL:
Oncogenic hypophosphatemic osteomalacia: From the first signal of
disease to the first signal of healthy. Int J Surg Case Rep.
30:130–133. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mok Y, Lee JC, Lum JH and Petersson F:
From epistaxis to bone pain-report of two cases illustrating the
clinicopathological spectrum of phosphaturic mesenchymal tumour
with fibroblast growth factor receptor 1 immunohistochemical and
cytogenetic analyses. Histopathology. 68:925–930. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Manara M and Sinigaglia L: ‘Slow and
steady wins the race’: The importance of perseverance in the
management of oncogenic osteomalacia. Endocrine. 57:1–2. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Leow MK, Hamijoyo L, Liew H, Thirugnanam
U, Cheng MH, Loke KS, Teo MS, Chuah KL and Chng HH: Oncogenic
osteomalacia presenting as a crippling illness in a young man.
Lancet. 384:12362014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kaniuka-Jakubowska S, Biernat W and
Sworczak K: Oncogenic osteomalacia and its symptoms:
Hypophosphatemia, bone pain and pathological fractures. Postepy Hig
Med Dosw (online). 66:554–567. 2012.(In Polish). View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chang CV, Conde SJ, Luvizotto RA, Nunes
VS, Bonates MC, Felicio AC, Lindsey SC, Moraes FH, Tagliarini JV,
Mazeto GM, et al: Oncogenic osteomalacia: Loss of hypophosphatemia
might be the key to avoid misdiagnosis. Arq Bras Endocrinol
Metabol. 56:570–573. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ogose A, Hotta T, Emura I, Hatano H, Inoue
Y, Umezu H and Endo N: Recurrent malignant variant of phosphaturic
mesenchymal tumor with oncogenic osteomalacia. Skeletal Radiol.
30:99–103. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pallavi R, Ravella PM, Gupta P and Popescu
A: A case of phosphaturic mesenchymal tumor. Am J Ther. 22:e57–e61.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fatani HA, Sunbuli M, Lai SY and Bell D:
Phosphaturic mesenchymal tumor: A report of 6 patients treated at a
single institution and comparison with reported series. Ann Diagn
Pathol. 17:319–321. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Suryawanshi P, Agarwal M, Dhake R, Desai
S, Rekhi B, Reddy KB and Jambhekar NA: Phosphaturic mesenchymal
tumor with chondromyxoid fibroma-like feature: An unusual
morphological appearance. Skeletal Radiol. 40:1481–1485. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Akhter M, Sugrue PA, Bains R and Khavkin
YA: Oncogenic osteomalacia of the cervical spine: A rare case of
curative resection and reconstruction. J Neurosurg Spine.
14:453–456. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sidell D, Lai C, Bhuta S, Barnes L and
Chhetri DK: Malignant phosphaturic mesenchymal tumor of the larynx.
Laryngoscope. 121:1860–1863. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hendry DS and Wissman R: Case 165:
Oncogenic osteomalacia. Radiology. 258:320–322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shelekhova KV, Kazakov DV, Hes O, Treska V
and Michal M: Phosphaturic mesenchymal tumor (mixed connective
tissue variant): A case report with spectral analysis. Virchows
Arch. 448:232–235. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Folpe AL, Fanburg-Smith JC, Billings SD,
Bisceglia M, Bertoni F, Cho JY, Econs MJ, Inwards CY, Jan de Beur
SM, Mentzel T, et al: Most Osteomalacia-associated mesenchymal
tumors are a single histopathologic entity: An analysis of 32 cases
and a comprehensive review of the literature. Am J Surg Pathol.
28:1–30. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lopresti M, Daolio PA, Rancati JM, Ligabue
N, Andreolli A and Panella L: Rehabilitation of a patient receiving
a large-resection hip prosthesis because of a phosphaturic
mesenchyal tumor. Clin Pract. 5:8142015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Angeles-Angeles A, Reza-Albarrán A,
Chable-Montero F, Cordova-Ramón JC, Albores-Saavedra J and
Martinez-Benitez B: Phosphaturic mesenchymal tumors. Survey of 8
cases from a single mexican medical institution. Ann Diagn Pathol.
19:375–380. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Honda R, Kawabata Y, Ito S and Kikuchi F:
Phosphaturic mesenchymal tumor, mixed connective tissue type,
non-phosphaturic variant: Report of a case and review of 32 cases
from the Japanese published work. J Dermatol. 41:845–849. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Deep NL, Cain RB, McCullough AE, Hoxworth
JM and Lal D: Sinonasal phosphaturic mesenchymal tumor: Case report
and systematic review. Allergy Rhinol (Providence). 5:162–167.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Papierska L, Ćwikła JB, Misiorowski W,
Rabijewski M, Sikora K and Wanyura H: Unusual case of phosphaturic
mesenchymal tumor. Pol Arch Med Wewn. 123:255–256. 2013.PubMed/NCBI
|
|
38
|
Gardner KH, Shon W, Folpe AL, Wieland CN,
Tebben PJ and Baum CL: Tumor-induced osteomalacia resulting from
primary cutaneous phosphaturic mesenchymal tumor: A case and review
of the medical literature. J Cutan Pathol. 40:780–784. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Graham RP, Hodge JC, Folpe AL, Oliveira
AM, Meyer KJ, Jenkins RB, Sim FH and Sukov WR: A cytogenetic
analysis of 2 cases of phosphaturic mesenchymal tumor of mixed
connective tissue type. Hum Pathol. 43:1334–1338. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bower RS, Daugherty WP, Giannini C and
Parney IF: Intracranial phosphaturic mesenchymal tumor, mixed
connective tissue variant presenting without oncogenic
osteomalacia. Surg Neurol Int. 3:1512012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Woo VL, Landesberg R, Imel EA, Singer SR,
Folpe AL, Econs MJ, Kim T, Harik LR and Jacobs TP: Phosphaturic
mesenchymal tumor, mixed connective tissue variant, of the
mandible: Report of a case and review of the literature. Oral Surg
Oral Med Oral Pathol Oral Radiol Endod. 108:925–932. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Reis-Filho JS, Paiva ME and Lopes JM:
Pathologic quiz case. A 36-year-old woman with muscle pain and
weakness. Phosphaturic mesenchymal tumor (mixed connective tissue
variant)/oncogenic osteomalacia. Arch Pathol Lab Med.
126:1245–1246. 2002.PubMed/NCBI
|
|
43
|
Singh D, Chopra A, Ravina M, Kongara S,
Bhatia E, Kumar N, Gupta S, Yadav S, Dabadghao P, Yadav R, et al:
Oncogenic osteomalacia: Role of Ga-68 DOTANOC PET/CT scan in
identifying the culprit lesion and its management. Br J Radiol.
90:201608112017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Basu S and Fargose P: 177Lu-DOTATATE PRRT
in recurrent skull-base phosphaturic mesenchymal tumor causing
osteomalacia: A potential application of PRRT beyond neuroendocrine
tumors. J Nucl Med Technol. 44:248–250. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kaneuchi Y, Hakozaki M, Yamada H, Hasegawa
O, Tajino T and Konno S: Missed causative tumors in diagnosing
tumor-induced osteomalacia with (18)F-FDG PET/CT: A potential
pitfall of standard-field imaging. Hell J Nucl Med. 19:46–48.
2016.PubMed/NCBI
|
|
46
|
Agrawal K, Bhadada S, Mittal BR, Shukla J,
Sood A, Bhattacharya A and Bhansali A: Comparison of 18F-FDG and
68Ga DOTATATE PET/CT in localization of tumor causing oncogenic
osteomalacia. Clin Nucl Med. 40:e6–e10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Breer S, Brunkhorst T, Beil FT, Peldschus
K, Heiland M, Klutmann S, Barvencik F, Zustin J, Gratz KF and
Amling M: 68Ga DOTA-TATE PET/CT allows tumor localization in
patients with tumor-induced osteomalacia but negative 111
In-octreotide SPECT/CT. Bone. 64:222–227. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jing H, Li F, Zhong D and Zhuang H: 99 m
Tc-HYNIC-TOC (99mTc-hydrazinonicotinyl-Tyr3-octreotide)
scintigraphy identifying two separate causative tumors in a patient
with tumor-induced osteomalacia (TIO). Clin Nucl Med. 38:664–667.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Nakanishi K, Sakai M, Tanaka H, Tsuboi H,
Hashimoto J, Hashimoto N and Tomiyama N: Whole-body MR imaging in
detecting phosphaturic mesenchymal tumor (PMT) in tumor-induced
hypophosphatemic osteomalacia. Magn Reson Med Sci. 12:47–52. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Andreopoulou P, Dumitrescu CE, Kelly MH,
Brillante BA, Cutler Peck CM, Wodajo FM, Chang R and Collins MT:
Selective venous catheterization for the localization of
phosphaturic mesenchymal tumors. J Bone Miner Res. 26:1295–1302.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hodgson SF, Clarke BL, Tebben PJ, Mullan
BP, Cooney WP III and Shives TC: Oncogenic osteomalacia:
Localization of underlying peripheral mesenchymal tumors with use
of Tc 99 m sestamibi scintigraphy. Endocr Pract. 12:35–42. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kimizuka T, Ozaki Y and Sumi Y: Usefulness
of 201Tl and 99mTc MIBI scintigraphy in a case of oncogenic
steomalacia. Ann Nucl Med. 18:63–67. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Jan de Beur SM, Streeten EA, Civelek AC,
McCarthy EF, Uribe L, Marx SJ, Onobrakpeya O, Raisz LG, Watts NB,
Sharon M, et al: Localisation of mesenchymal tumours by
somatostatin receptor imaging. Lancet. 359:761–763. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Reubi JC, Waser B, Laissue JA and Gebbers
JO: Somatostatin and vasoactive intestinal peptide receptors in
human mesenchymal tumors: In vitro identification. Cancer Res.
56:1922–1931. 1996.PubMed/NCBI
|
|
55
|
Kong X, Liu Y, Li Y, Zhai Y and Wu Dan:
Imaging diagnosis of tumor-induced osteomalacia. Chin J Med
Imaging. 22:624–629. 2014.(In Chinese).
|
|
56
|
Cowan S, Lozano-Calderon SA, Uppot RN,
Sajed D and Huang AJ: Successful CT guided cryoablation of
phosphaturic mesenchymal tumor in the soft tissues causing
tumor-induced osteomalacia: A case report. Skeletal Radiol.
46:273–277. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Fukumoto S, Takeuchi Y, Nagano A and
Fujita T: Diagnostic utility of magnetic resonance imaging skeletal
survey in a patient with oncogenic osteomalacia. Bone. 25:375–377.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Avila NA, Skarulis M, Rubino DM and
Doppman JL: Oncogenic osteomalacia: Lesion detection by MR skeletal
survey. AJR Am J Roentgenol. 167:343–345. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Monappa V, Naik AM, Mathew M, Rao L, Rao
SK, Ramachandra L and PadmaPriya J: Phosphaturic mesenchymal tumour
of the mandible-the useful criteria for a diagnosis on fine needle
aspiration cytology. Cytopathology. 25:54–56. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ulas A, Dede DS, Sendur MA, Akinci MB and
Yalcin B: Expectations of response from octreotide therapy in
recurrent phosphaturic mesenchymal tumors-do they reflect reality?
Asian Pac J Cancer Prev. 15:10997–10998. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Dezfulian M and Wohlgenannt O: Revision
hip arthroplasty following recurrence of a phosphaturic mesenchymal
tumor. J Surg Case Rep. 9(pii): rjt0592013.
|
|
62
|
Allevi F, Rabbiosi D, Mandalà M and
Colletti G: Mesenchymal phosphaturic tumour: Early detection of
recurrence. BMJ Case Rep. 2014:bcr20132028272014. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kimura S, Yanagisawa M, Fujita Y, Sakihara
S, Hisaoka M and Kurose A: A case of phosphaturic mesenchymal tumor
of the pelvis with vascular invasion. Pathol Int. 65:510–512. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Syed MI, Chatzimichalis M, Rössle M and
Huber AM: Recurrent phosphaturic mesenchymal tumour of the temporal
bone causing deafness and facial nerve palsy. J Laryngol Otol.
126:721–724. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Okiror L, Khalil H, Vaiyapuri S and Kalkat
M: Complete resection of a large phosphaturic mesenchymal tumour by
chest wall resection and reconstruction. Gen Thorac Cardiovasc
Surg. 64:355–358. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Farmakis SG and Siegel MJ: Phosphaturic
mesenchymal tumor of the tibia with oncogenic osteomalacia in a
teenager. Pediatr Radiol. 45:1423–1426. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Tarasova VD, Trepp-Carrasco AG, Thompson
R, Recker RR, Chong WH, Collins MT and Armas LA: Successful
treatment of tumor-induced osteomalacia due to an intracranial
tumor by fractionated stereotactic radiotherapy. J Clin Endocrinol
Metab. 98:4267–4272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Chong WH, Andreopoulou P, Chen CC,
Reynolds J, Guthrie L, Kelly M, Gafni RI, Bhattacharyya N, Boyce
AM, El-Maouche D, et al: Tumor localization and biochemical
response to cure in tumor-induced osteomalacia. J Bone Miner Res.
28:1386–1398. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Imanishi Y, Hashimoto J, Ando W, Kobayashi
K, Ueda T, Nagata Y, Miyauchi A, Koyano HM, Kaji H, Saito T, et al:
Matrix extracellular phosphoglycoprotein is expressed in causative
tumors of oncogenic osteomalacia. J Bone Miner Metab. 30:93–99.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Jiang Y, Xia WB, Xing XP, Silva BC, Li M,
Wang O, Zhang HB, Li F, Jing HL, Zhong DR, et al: Tumor-induced
osteomalacia: An important cause of adult-onset hypophosphatemic
osteomalacia in China: Report of 39 cases and review of the
literature. J Bone Miner Res. 27:1967–1975. 2012. View Article : Google Scholar : PubMed/NCBI
|
